InspireMD, Inc.
NSPR
$1.18
$0.043.51%
NASDAQ
| 12/31/2025 | 09/30/2025 | ||||
|---|---|---|---|---|---|
| Revenue | 24.81% | 41.90% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 24.81% | 41.90% | |||
| Cost of Revenue | 18.69% | 13.24% | |||
| Gross Profit | 36.57% | 176.04% | |||
| SG&A Expenses | -4.78% | 8.23% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -2.19% | 5.25% | |||
| Operating Income | 7.41% | -0.25% | |||
| Income Before Tax | 7.95% | 3.37% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | 7.45% | 3.37% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 7.45% | 3.37% | |||
| EBIT | 7.41% | -0.25% | |||
| EBITDA | 7.60% | -0.09% | |||
| EPS Basic | 17.46% | 32.89% | |||
| Normalized Basic EPS | 17.85% | 32.94% | |||
| EPS Diluted | 17.46% | 32.89% | |||
| Normalized Diluted EPS | 17.85% | 32.94% | |||
| Average Basic Shares Outstanding | 12.12% | 44.04% | |||
| Average Diluted Shares Outstanding | 12.12% | 44.04% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||